Filing Details
- Accession Number:
- 0001213900-19-021415
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-29 20:26:54
- Reporting Period:
- 2019-10-25
- Accepted Time:
- 2019-10-29 20:26:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1733413 | Tff Pharmaceuticals Inc. | TFFP | Pharmaceutical Preparations (2834) | 824344737 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1789490 | G.l. Aaron Fletcher | 2600 Via Fortuna, Suite 360 Austin TX 78746 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-10-25 | 2,000 | $5.00 | 2,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-10-29 | 43,919 | $0.00 | 45,919 | No | 4 | C | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | C | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants | Acquisiton | 2019-10-29 | 43,794 | $0.00 | 43,794 | $5.00 |
| Common Stock | Series A Preferred Stock | Disposition | 2019-10-29 | 43,919 | $0.00 | 43,919 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 179,693 | 2029-10-29 | No | 4 | A | Indirect | |
| 135,806 | No | 4 | C | Direct |
Footnotes
- The shares of common stock purchased in the Issuer's initial public offering ("IPO").
- The shares of Series A preferred stock automatically converted into the Issuer's common stock upon the completion of the Issuer's IPO at the conversion price of $2.50 per share.
- 25% of the warrants vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years.
- Not Applicable.
Billionaire Hedge Funds
